Dementia and neurodegeneration - A window of opportunity
UCL has the expertise to have a significant impact on the treatment of dementia and other neurodegenerative diseases – and the commitment to make it happen.
Research at UCL encompasses the full spectrum of dementia, from studies of the basic mechanisms causing dementia through to the development of new clinical treatments.
Dementia and neurodegeneration is a key priority for UCL neuroscience. In part this reflects a desire to build on UCL’s undoubted strengths in this area. But it is also a recognition that dementia and neurodegeneration are a national and international priority.
Currently, there is little that can be done to tackle the root causes of dementia. However, the hope is that by pulling together the breadth and depth of research expertise across UCL, that researchers here will have a major impact on this disease, which is one greatest and growing challenges to health systems worldwide
This strategy provides an insight into some of the work on dementia and neurodegeneration being carried out across UCL, in collaboration with national and international academic collaborators, and UCL’s industrial partners.
- Fundamental research: From molecules to neural circuitry
- Translational research: Genetic insights, disease models and intervention development
- Patient-oriented research: Understanding, and preventing, brain atrophy
- Social and health research: Essential support for patients and carers